Our research is within basic sarcoma biology with the aim to outline molecular mechanism of tumor development whit the ultimate goal to develop targeted therapies. Furthermore, we are developing and implementing next generation cancer diagnostics based on liquid biopsy-based biomarker analysis in cancer management. To accomplish these efforts, we have developed several molecular technologies and have access to our own clinical trial.
Anders Ståhlberg
University of Gothenburg
Key Publications
Disabling aggressive colorectal cancer by dual targeting of cancer cells and the microenvironment
Cancer Letters, 2026
Modeling cancer-associated fibroblast plasticity and breast cancer interactions using patient-derived scaffolds
Biomedicine & Pharmacotherapy, 2026
Longitudinal ctDNA monitoring in patients with metastatic uveal melanoma undergoing isolated hepatic perfusion in combination with ipilimumab and nivolumab
Immuno-Oncology and Technology, 2025
Identification of protein biomarkers to differentiate between gram-negative and gram-positive infections in adults suspected of sepsis
BMC Infectious Diseases, 2025